Endometrial Adenocarcinoma Clinical Trials

55 clinical trials for Endometrial Adenocarcinoma across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma — RECRUITING · PHASE2
• DBC-664 in Adult Patients With Solid Tumors — RECRUITING · PHASE1
• Clonal Hematopoiesis Chemotherapy and Radiation Effects Study — RECRUITING
• A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma — RECRUITING · PHASE2
• Surgical and Obstetric Outcomes in Endometrial Adenocarcinoma and Atypical Endometrial Hyperplasia With Conservative Treatment — RECRUITING
• QL1706-Based Therapy Post-PD-1/L1 Failure in Advanced Endometrial Cancer — RECRUITING · PHASE2
• PErsonalized TReatment for Endometrial Carcinoma — RECRUITING · NA
• Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone — ACTIVE_NOT_RECRUITING · PHASE2
• A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer — COMPLETED · PHASE1
• mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian — ACTIVE_NOT_RECRUITING · PHASE1
• Comparison of Sentinel Lymph Node Applications in Endometrial Cancer Cases Performed With Vaginal Natural Orifice Transluminal Endoscopic Surgery (V-NOTES) and Conventional Laparoscopy — NOT_YET_RECRUITING
• TREAT-EC (Tirzepatide in the treatment of endometrial cancer) - a clinical trial — NOT_YET_RECRUITING · PHASE2
• Study of Cadonilimab (AK104) Plus Lenvatinib in Patients With Advanced Endometrial Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment — ACTIVE_NOT_RECRUITING · PHASE2
• Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care — COMPLETED · NA
• Prognosis of METTL-14 in Endometrial Carcinoma — NOT_YET_RECRUITING
• V-Notes Hysterectomy in Patients With Endometrial cáncer Compared With Laparoscopic Surgery (Robotically Assisted or Not): ENOLA TRIAL — COMPLETED · NA
• A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) — TERMINATED · PHASE1
• [SENTRY] Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk Endometrial Cancer — COMPLETED · NA
• Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer — NOT_YET_RECRUITING · PHASE2
• Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer — TERMINATED · PHASE2
• AMT-151 in Patients With Selected Advanced Solid Tumours — OTHER · PHASE1
• Diagnostic and Prognostic Value of PTEN Expression in Functional and Pathological Endometrial Biopsies — COMPLETED
• Pembro/Carbo/Taxol in Endometrial Cancer — COMPLETED · PHASE2
• PEN-866 in Patients With Advanced Solid Malignancies — OTHER · PHASE1
• Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer — COMPLETED · PHASE2
• Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer — OTHER · PHASE2
• Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma — COMPLETED · PHASE2
• Trametinib With or Without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial Cancer — COMPLETED · PHASE1
• Evaluation of the Efficacy for Sentinel Lymph Node Policy in High-risk Endometrial Carcinoma — COMPLETED
• Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer — COMPLETED · PHASE2
• Effects of Wound Infiltration With Ketamine Versus Dexmedetomidine Added to Bupivacaine on Cytokines — COMPLETED · PHASE4
• Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer — COMPLETED · PHASE2
• Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer — COMPLETED · PHASE2
• Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer — COMPLETED · PHASE2
• Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer — COMPLETED · PHASE2
• Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer — WITHDRAWN · PHASE2
• Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer — COMPLETED · PHASE1
• Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer — COMPLETED · PHASE2
• Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer — COMPLETED · PHASE2
• Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer — COMPLETED · PHASE2
• Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer — COMPLETED · PHASE2
• Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer — COMPLETED · PHASE2
• Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer — COMPLETED · PHASE2
• Prognostic Biomarkers in Patients With Endometrial Cancer — COMPLETED
• Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus — COMPLETED · PHASE2
• Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus — COMPLETED · PHASE3
• Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer — COMPLETED · PHASE3

Refine this search